Search research articles
Contact Us
Filters
Showing results (351-360 of 570) with videos related to
Page
of 57
Sort By:
ACS Chemical Biology
|
May 28, 2011
Selective inhibition of the K(ir)2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133
Hao-Ran Wang, Meng Wu, Haibo Yu, et al.
ACS Chemical Neuroscience
|
September 20, 2011
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction
Craig W Lindsley, Brittney S Bates, Usha N Menon, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2022
Discovery of a potent M<sub>5</sub> antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonists
Douglas L Orsi, Andrew S Felts, Alice L Rodriguez, et al.
ACS Medicinal Chemistry Letters
|
January 12, 2013
Discovery of N-Aryl Piperazines as Selective mGlu(5) Potentiators with Efficacy in a Rodent Model Predictive of Anti-Psychotic Activity
Ya Zhou, Jason T Manka, Alice L Rodriguez, et al.
Journal of Medical Genetics
|
December 6, 2018
Kabuki syndrome: international consensus diagnostic criteria
Margaret P Adam, Siddharth Banka, Hans T Bjornsson, et al.
Cancer Research
|
May 14, 2009
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer
Todd W Miller, Marianela Pérez-Torres, Archana Narasanna, et al.
Assay and Drug Development Technologies
|
February 17, 2026
Identification of Kir2.1 Inhibitors from a High-Throughput Screen
Jacob L Bouchard, Pedro de Andrade Horn, Yu Nishio, et al.
Research Square
|
April 16, 2025
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Science Signaling
|
November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease
Louis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
Alzheimer'S Research & Therapy
|
July 2, 2025
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M<sub>1</sub> positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Page
of 57
Search research articles
Search
Showing results (351-360 of 570) with videos related to
Sort By:
Page
of 57
ACS Chemical Biology
|
May 28, 2011
Selective inhibition of the K(ir)2 family of inward rectifier potassium channels by a small molecule probe: the discovery, SAR, and pharmacological characterization of ML133
Hao-Ran Wang, Meng Wu, Haibo Yu, et al.
ACS Chemical Neuroscience
|
September 20, 2011
(3-Cyano-5-fluorophenyl)biaryl negative allosteric modulators of mGlu(5): Discovery of a new tool compound with activity in the OSS mouse model of addiction
Craig W Lindsley, Brittney S Bates, Usha N Menon, et al.
Bioorganic & Medicinal Chemistry Letters
|
October 13, 2022
Discovery of a potent M<sub>5</sub> antagonist with improved clearance profile. Part 2: Pyrrolidine amide-based antagonists
Douglas L Orsi, Andrew S Felts, Alice L Rodriguez, et al.
ACS Medicinal Chemistry Letters
|
January 12, 2013
Discovery of N-Aryl Piperazines as Selective mGlu(5) Potentiators with Efficacy in a Rodent Model Predictive of Anti-Psychotic Activity
Ya Zhou, Jason T Manka, Alice L Rodriguez, et al.
Journal of Medical Genetics
|
December 6, 2018
Kabuki syndrome: international consensus diagnostic criteria
Margaret P Adam, Siddharth Banka, Hans T Bjornsson, et al.
Cancer Research
|
May 14, 2009
Loss of Phosphatase and Tensin homologue deleted on chromosome 10 engages ErbB3 and insulin-like growth factor-I receptor signaling to promote antiestrogen resistance in breast cancer
Todd W Miller, Marianela Pérez-Torres, Archana Narasanna, et al.
Assay and Drug Development Technologies
|
February 17, 2026
Identification of Kir2.1 Inhibitors from a High-Throughput Screen
Jacob L Bouchard, Pedro de Andrade Horn, Yu Nishio, et al.
Research Square
|
April 16, 2025
Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M 1 Positive Allosteric Modulator VU0467319 for Alzheimer's disease: A Single Ascending-Dose Study in Healthy Participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Science Signaling
|
November 15, 2022
M<sub>1</sub> muscarinic receptor activation reduces the molecular pathology and slows the progression of prion-mediated neurodegenerative disease
Louis Dwomoh, Mario Rossi, Miriam Scarpa, et al.
Alzheimer'S Research & Therapy
|
July 2, 2025
Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M<sub>1</sub> positive allosteric modulator VU0467319 for Alzheimer's disease: a single ascending-dose study in healthy participants
Alexander C Conley, Alexandra P Key, Jennifer U Blackford, et al.
Page
of 57